Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2012-10-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cranberry Enhances Human Immune Function and Reduces Illness
NCT01398150
Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress
NCT01780922
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
NCT03957239
Cranberry Ingestion and Cycling Related Immunity and Inflammation
NCT05407701
Effects of Cranberry Juice on Cardiovascular Risk Factors
NCT02556749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cranberry Beverage
Cranberry Beverage is provided in an 8 oz daily beverage consumed once daily for 12 weeks
Cranberry Beverage
8 oz cranberry beverage consumed daily for 12 weeks
Placebo Beverage
The placebo beverage looks like the active arm and is given in the same way but contains no active ingredient.
Placebo Beverage
8 oz placebo beverage consumed daily for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cranberry Beverage
8 oz cranberry beverage consumed daily for 12 weeks
Placebo Beverage
8 oz placebo beverage consumed daily for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a BMI between 18.5 and 29.9
* willing to consume the study beverage for 12 weeks
* willing to have a small amount of blood drawn two times
* willing to stop consuming tea and immune-enhancing dietary supplements (e.g. antioxidant-, probiotic-, or flavonoid-containing supplements, fish oil, and Echinacea) before and during the 12 weeks of the study
* willing to consume no more than 7 servings of fruits and vegetables a day
* willing to limit your alcohol consumption to no more than 14 glasses a week
* willing to limit your yogurt consumption to no more than one 8oz. serving per day
Exclusion Criteria
* have hypertension
* taking non-steroidal anti-inflammatory drugs on a chronic basis, antibiotics, or immunosuppressive drugs
* sensitive to aspirin or prone to kidney stones
* current smoker
* pregnant, lactating, or on hormone therapy, except for birth control pills
21 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cranberry Institute
OTHER
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan S Percival, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
449 Food Science and Human Nutrition Department, University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB-472-2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.